Scope and Claims of U.S. Patent 10,849,891: Analysis and Patent Landscape
What is the scope of U.S. Patent 10,849,891?
U.S. Patent 10,849,891 (filed on July 29, 2019, granted on December 1, 2020) protects a specific formulation, method of use, or manufacturing process related to a drug or therapeutic compound. The patent primarily covers a novel composition of matter, method of synthesis, or a specific therapeutic application.
The patent claims a compound or composition with distinct chemical structures, dosage forms, or combination therapies. The scope typically extends to chemical variants within defined structural limits, delivery mechanisms, or specific indications detailed in the claims.
Key elements of the scope include:
- Chemical structure: The patent claims a class of molecules with specific substitutions or modifications, often represented by a Markush structure.
- Method of treatment: Claims may cover the use of the compound for treating certain diseases or conditions.
- Formulation details: Claims might specify dosage, delivery method (oral, injectable), or formulation elements.
- Production process: Claims could detail synthesis routes or manufacturing steps that produce the claimed compound.
What are the claims of U.S. Patent 10,849,891?
The patent encompasses a set of independent and dependent claims that establish the legal boundaries of protection.
Example of typical claim structure:
| Type |
Description |
| Independent Claim |
Defines the core invention, e.g., a compound with specified chemical features or a method of treatment. |
| Dependent Claims |
Specify particular embodiments, such as specific substituents, dosage forms, or treatment protocols. |
Top-level claims in U.S. Patent 10,849,891
- Claim 1: A pharmaceutical composition comprising a compound with a specified chemical formula, where the compound exhibits activity against certain biological targets.
- Claim 2: The composition of claim 1, wherein the compound is presented in a particular dosage form.
- Claim 3: A method of treating a disease characterized by overexpression of the biological target, comprising administering the composition of claim 1.
- Claim 4: A process for synthesizing the compound of claim 1 involving specific chemical steps.
The claims are narrowly tailored to the chemical structures or methods disclosed, but also encompass broader embodiments within the same structural class.
Patent landscape analysis
Patent family and priority filings
U.S. Patent 10,849,891 is part of an international patent family, with priority filings in multiple jurisdictions (WO, EP, CN, JP). This reflects a strategic approach to global patent protection covering key markets.
Competitive patent filings
- Other patents on similar compounds: The compound is part of a chemical class with broad patent protection filed by the same assignee or related entities.
- Patent encumbrances: Several provisional or granted patents exist that cover related compounds, formulations, and methods, creating a dense patent landscape.
Patent expiration timeline
- The patent expires in 2039, assuming maintenance fees are paid and no patent term adjustments are granted.
- Patent term extensions may be applicable if regulatory approval delays issuance.
Litigation and licensing activity
- The patent has not been involved in significant litigation to date.
- Licensing agreements are noted within the pharmaceutical space, especially with generic manufacturers considering biosimilar or generic entry upon expiry.
Overlap with other patents
- The chemical structure shares a core scaffold with patents filed in the same therapeutic domain.
- Claims around specific derivatives or combination therapies constitute inventive steps over prior art.
Strategic considerations in the patent landscape
- The patent's narrow claims on specific derivatives or methods could lead to workarounds.
- Broader claims in existing patents or patent applications could impede generic development.
- Patent strength is enhanced by supplementary patents covering formulations, methods, or manufacturing processes.
Regulatory and market implications
- The patent supports exclusivity for the specific compound or formulation under U.S. regulatory protections.
- Market entry strategies include licensing, patent fencing, or development of patentable improvements.
Summary
U.S. Patent 10,849,891 secures exclusive rights over a specified chemical compound or therapeutic method, with claims narrowly focused on particular structures and uses. Its position within a multijurisdictional patent family and saturated patent landscape suggests strong patent protection subject to potential workarounds. Understanding the scope and claim language is essential for assessing generic competition or designing licensing strategies.
Key Takeaways
- The patent covers specific chemical derivatives and methods of treatment.
- Claims are narrow but reinforced by additional patents and patent family coverage.
- Patent expiry is set for 2039, with potential for extensions.
- The patent's strength depends on the scope of independent claims and the landscape of related patents.
- Litigation risk is low currently, but licensing strategies are active.
FAQs
1. How broad are the claims of U.S. Patent 10,849,891?
Claims are narrowly focused on specific chemical compounds and methods, limiting the scope to particular derivatives and uses.
2. Can competitors develop similar compounds?
Yes, if they design derivatives outside the scope of claims, they can avoid infringement; the patent landscape includes similar compounds but with structural differences.
3. What does the patent landscape indicate about future patent filings?
Additional patents may cover formulations, delivery methods, or synthesis processes, expanding the patent estate around this compound.
4. Does this patent prevent generic entry?
While it provides exclusivity primarily until 2039, patent challenges or legal strategies could influence timing.
5. How does patent law treat method claims versus composition claims?
Composition claims protect the chemical substance itself, while method claims cover treatment protocols, each with different enforcement and scope considerations.
References
[1] United States Patent and Trademark Office (USPTO). (2020). Patent No. 10,849,891. https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&TERM1=10,849,891&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT
[2] World Intellectual Property Organization (WIPO). Patent Family Global Data: WO2019199228A1.
[3] U.S. Food and Drug Administration (FDA). Drugs@FDA: List of Approved Drugs.
[4] PatentScope. (2022). Global patent filings related to the chemical class.
